Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study

Altuntaş F., Aydoğdu I., Kabukcu S., Kocyigit I., Çıkım K., Sarı I., ...Daha Fazla

TRANSFUSION AND APHERESIS SCIENCE, cilt.36, sa.1, ss.57-67, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 1
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1016/j.transci.2006.05.014
  • Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.57-67
  • Anahtar Kelimeler: therapeutic plasma exchange, thrombotic thrombocytopenic purpura, treatment, outcome, HEMOLYTIC-UREMIC SYNDROME, VON-WILLEBRAND-FACTOR, SYSTEMIC-LUPUS-ERYTHEMATOSUS, BONE-MARROW TRANSPLANTATION, FACTOR-CLEAVING PROTEASE, SINGLE-CENTER EXPERIENCE, IMPROVED SURVIVAL, UNITED-STATES, CRYOSUPERNATANT, RITUXIMAB
  • Erciyes Üniversitesi Adresli: Evet

Özet

Background: Thrombotic thrombocytopenic purpura (TTP) is a rare disease that is fatal if it is not treated. Therapeutic plasma exchange (TPE) has resulted in excellent remission and survival rates in TTP patients.